Authors
Loading...
Integrated analysis identifies uridine phosphatase 1 as a promising biomarker and therapeutic target in gastric cancer, highlighting its role in patient prognosis.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: